Literature DB >> 6144680

Human placental lysyl oxidase. Purification, partial characterization, and preparation of two specific antisera to the enzyme.

H Kuivaniemi, E R Savolainen, K I Kivirikko.   

Abstract

Lysyl oxidase from human placentas gave four catalytically active forms on DEAE-cellulose chromatography in 6 M urea. The first tow of these were combined to form pool I and the remaining two to form pool II. Pool I was purified to homogeneity, while the final pool II enzyme usually had one minor contaminant. The molecular weight of both enzyme pools was identical, being about 30,000 by gel filtration in 6 M urea and by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. No distinct differences were found between the two pools in amino acid composition, specific activity, or the use of various substrates. Two antisera were prepared, one to the total enzyme protein (pools I and II) and the other to pool I. Both antisera inhibited and precipitated crude placental lysyl oxidase, the two enzyme pools, and crude human skin fibroblast enzyme, there being no differences between the various enzyme forms. Both antisera also stained the two enzyme pools in immunoblotting of denatured proteins. The data suggest that there are no major catalytic, molecular, or immunological differences between the multiple forms of human lysyl oxidase. An antiserum prepared to any of the enzyme forms can, therefore, probably be used to study the total enzyme protein.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6144680

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  Characterizing a human lysyl oxidase chromosomal domain.

Authors:  R P Martins; S A Krawetz
Journal:  Mol Biotechnol       Date:  2000-07       Impact factor: 2.695

2.  Purification of lysyl oxidase from piglet skin by selective interaction with Sephacryl S-200.

Authors:  D R Shackleton; D J Hulmes
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

3.  Type IX Ehlers-Danlos syndrome and Menkes syndrome: the decrease in lysyl oxidase activity is associated with a corresponding deficiency in the enzyme protein.

Authors:  H Kuivaniemi; L Peltonen; K I Kivirikko
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

4.  Partial characterization of lysyl oxidase from several human tissues.

Authors:  H Kuivaniemi
Journal:  Biochem J       Date:  1985-09-15       Impact factor: 3.857

5.  Purification, properties and influence of dietary copper on accumulation and functional activity of lysyl oxidase in rat skin.

Authors:  N Romero-Chapman; J Lee; D Tinker; J Y Uriu-Hare; C L Keen; R R Rucker
Journal:  Biochem J       Date:  1991-05-01       Impact factor: 3.857

6.  The size heterogeneity of human lysyl oxidase mRNA is due to alternate polyadenylation site and not alternate exon usage.

Authors:  C D Boyd; T J Mariani; Y Kim; K Csiszar
Journal:  Mol Biol Rep       Date:  1995       Impact factor: 2.316

7.  Detection of lysyl oxidase gene expression in rat skin during wound healing.

Authors:  H Fushida-Takemura; M Fukuda; N Maekawa; M Chanoki; H Kobayashi; N Yashiro; M Ishii; T Hamada; S Otani; A Ooshima
Journal:  Arch Dermatol Res       Date:  1996       Impact factor: 3.017

8.  Inhibition of chick embryo lysyl oxidase by various lathyrogens and the antagonistic effect of pyridoxal.

Authors:  C I Levene; D F Sharman; B A Callingham
Journal:  Int J Exp Pathol       Date:  1992-10       Impact factor: 1.925

9.  Collagen metabolism in fibrotic liver. Effects of concanavalin A and aggregated myeloma immunoglobin G.

Authors:  S Takahashi; M J Lee
Journal:  Biochem J       Date:  1987-01-01       Impact factor: 3.857

10.  Covalently bound pyrroloquinoline quinone is the organic prosthetic group in human placental lysyl oxidase.

Authors:  R A van der Meer; J A Duine
Journal:  Biochem J       Date:  1986-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.